Cardiometabolic Disease Risk Reduction Following Bariatric Surgery Among Hispanic Adults
Nestor de la Cruz-Muñoz, Gabriela Lopez-Mitnik, Kristopher L. Arheart, Alan Livingstone, Steven E. Lipshultz, Tracie L. Miller, Sarah E. Messiah
- This study found that bariatric surgery significantly reduced the risk of serious heart and metabolic health problems — including type 2 diabetes, high blood pressure, high cholesterol, and metabolic syndrome — specifically among Hispanic adults. The benefits went well beyond weight loss alone.
- Hispanic adults in the United States face higher rates of type 2 diabetes, metabolic syndrome, and cardiovascular disease compared with the general population. This study provided important evidence that bariatric surgery is highly effective at improving these conditions in Hispanic patients specifically.
- The improvements in diabetes were particularly notable, with many patients achieving complete resolution of their type 2 diabetes after surgery. Improvements in blood pressure and cholesterol were also significant, reducing the overall risk of heart disease and stroke.
- Dr. de la Cruz-Muñoz led this research as the first author, reflecting his commitment to studying outcomes in the community he serves. His practice in Miami treats a predominantly Hispanic patient population, and this study demonstrates that he has specifically researched and published on how bariatric surgery benefits Hispanic patients.
- For patients in the Miami area who are managing diabetes, high blood pressure, or high cholesterol alongside obesity, this study shows that bariatric surgery can address multiple health conditions at once — not just help with weight loss, but meaningfully improve the metabolic and cardiovascular health problems that often accompany severe obesity.
This study published in the Journal of Cardiometabolic Syndrome and Related Disorders (now Metabolic Syndrome and Related Disorders) analyzed cardiometabolic disease risk reduction following bariatric surgery specifically among Hispanic adults. Using data from a multiethnic bariatric surgery cohort at the University of Miami, the study examined changes in the prevalence of metabolic syndrome components — including type 2 diabetes mellitus, hypertension, hyperlipidemia, and the full metabolic syndrome — following laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic adjustable gastric banding (LAGB). The results demonstrated significant reductions in the prevalence of all cardiometabolic risk factors following bariatric surgery among Hispanic adults, with particularly notable improvements in type 2 diabetes resolution and hypertension control. The study provided critical evidence that bariatric surgery is not only effective for weight loss but also produces meaningful cardiometabolic improvements in the Hispanic population — a demographic disproportionately affected by metabolic syndrome, type 2 diabetes, and cardiovascular disease. These findings are especially relevant to clinical practice in South Florida, where the patient population is predominantly Hispanic and faces elevated cardiometabolic risk profiles compared with the general US population. Dr. de la Cruz-Muñoz is the first author, reflecting his leadership in generating Hispanic-specific bariatric surgery outcomes data.
De La Cruz-Muñoz N, Lopez-Mitnik G, Arheart KL, Livingstone A, Lipshultz SE, Miller TL, Messiah SE. Cardiometabolic Disease Risk Reduction Following Bariatric Surgery Among Hispanic Adults. Metabolic Syndrome and Related Disorders. 2013;11(4):262-266. doi:10.1089/met.2012.0172. PMID: 23611341.
